Barclays Maintains Equal-Weight on CME Gr, Raises Price Target to $219
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Benjamin Budish maintains an Equal-Weight rating on CME Group (NASDAQ:CME) and raises the price target from $209 to $219.
October 07, 2024 | 6:48 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barclays analyst Benjamin Budish maintains an Equal-Weight rating on CME Group and raises the price target from $209 to $219, indicating a positive outlook.
The increase in the price target from $209 to $219 by Barclays suggests a positive outlook for CME Group, which could lead to a short-term increase in stock price. The Equal-Weight rating indicates a neutral stance, but the raised target price is a positive signal.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100